← Leaderboards
Jose A Luchsinger
Columbia University Health Sciences
$109,144,238
Attributed
$170,918,452
Total exposure
25
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $42.3M · FY2005–25$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$249,301,285 · 28
By mechanism
R01$142,644,652 · 9
U19$73,098,629 · 5
RF1$9,721,427 · 1
P60$9,126,052 · 2
P30$4,998,068 · 3
U01$2,533,483 · 1
Top collaborators
- Kathleen M Hayden11 shared
- Timothy M. Hughes8 shared
- Marinella Temprosa8 shared
- Davangere P Devanand7 shared
- Mary Sherman Mittelman7 shared
- Suzanne Bakken6 shared
- David M Nathan6 shared
- Mark Andrew Espeland5 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Victoria H. Raveis$5,414,260
- Suzanne Bakken$19,982,764
- Mildred Ramirez$337,963
- Henry N Ginsberg$119,772,603
- Rajesh Narendran$16,481,808
Others in their field
Top investigators on “Alzheimer&Apos”
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
- Denis A Evans · Rush University Medical Center$28,117,218
Research focus
Alzheimer&AposS DiseasePersonsParticipantDementiaBrainImpaired CognitionBiological MarkersCerebrovascular DisordersDiabetes MellitusMagnetic Resonance ImagingS Disease Related DementiaBaseResourcesResponsePositron-Emission TomographyCognitiveAmyloidNerve DegenerationFundingMemoryBrain ImagingMild Cognitive ImpairmentHispanics
Grant awards (121)
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$15,462,979
U19 · FY2025 · AG · contact PI
Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease$9,592,233
R01 · FY2025 · AG
Metformin in Alzheimer's dementia Prevention (MAP)$6,451,136
R01 · FY2025 · AG · contact PI
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)$4,677,012
R01 · FY2025 · AG
Diabetes and brain amyloid in middle aged Hispanics$3,379,069
R01 · FY2025 · AG · contact PI
Administrative Core$1,203,234
U19 · FY2025 · AG · contact PI
Midcareer Award for Research in Dementia Risk Factors and Prevention$121,097
K24 · FY2025 · AG · contact PI
Association of cumulative exposure to metformin and other T2D medications with cognitive impairment and AD/ADRD biomarkers$81,379
U19 · FY2025 · AG · contact PI
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,500,642
U19 · FY2024 · AG · contact PI
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)$4,759,428
R01 · FY2024 · AG
Diabetes and brain amyloid in middle aged Hispanics$3,467,959
R01 · FY2024 · AG · contact PI
Impact of environmental toxicants on AD and ADRD risk in the Diabetes Prevention Program Outcomes study AD/ADRD project$2,533,483
U01 · FY2024 · AG · contact PI
Administrative Core$1,293,527
U19 · FY2024 · AG · contact PI
Measurement and estimation of lucidity prevalence in persons with dementia and neurological disorders$761,931
R33 · FY2024 · AG
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$250,000
U19 · FY2024 · AG · contact PI
Midcareer Award for Research in Dementia Risk Factors and Prevention$121,710
K24 · FY2024 · AG · contact PI
Association of cumulative exposure to metformin and other T2D medications with cognitive impairment and AD/ADRD biomarkers$93,088
U19 · FY2024 · AG · contact PI
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,850,168
U19 · FY2023 · AG · contact PI
Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease$11,038,947
R01 · FY2023 · AG
Metformin in Alzheimer's dementia Prevention (MAP)$8,176,191
R01 · FY2023 · AG · contact PI
Diabetes and brain amyloid in middle aged Hispanics$3,132,512
R01 · FY2023 · AG · contact PI
Administrative Core$1,752,974
U19 · FY2023 · AG · contact PI
Measurement and estimation of lucidity prevalence in persons with dementia and neurological disorders$806,020
R33 · FY2023 · AG
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$250,000
U19 · FY2023 · AG · contact PI
Pilot-Core$140,370
P30 · FY2023 · AG · contact PI
Midcareer Award for Research in Dementia Risk Factors and Prevention$121,252
K24 · FY2023 · AG · contact PI
Association of cumulative exposure to metformin and other T2D medications with cognitive impairment and AD/ADRD biomarkers$68,525
U19 · FY2023 · AG · contact PI
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,957,778
U19 · FY2022 · AG · contact PI
Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease$9,664,204
R01 · FY2022 · AG
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi Ethnic Study of Atherosclerosis (MESA) Multisite Studyof AD$3,776,527
R01 · FY2022 · AG
Diabetes and brain amyloid in middle aged Hispanics$3,169,894
R01 · FY2022 · AG · contact PI
Administrative Core$2,002,881
U19 · FY2022 · AG · contact PI
Are there ethnic differences in brain amyloid and tau in the seventh decade of life?$1,424,814
R01 · FY2022 · AG · contact PI
Measurement and estimation of lucidity prevalence in persons with dementia and neurological disorders$711,437
R33 · FY2022 · AG
Columbia Center for Interdisciplinary Research on Alzheimer's Disease Disparities (CIRAD)$676,807
P30 · FY2022 · AG
Research Education Core$264,991
P30 · FY2022 · AG · contact PI
DPPOS AD/ADRD Health Economics Evaluation$250,000
U19 · FY2022 · AG · contact PI
Midcareer Award for Research in Dementia Risk Factors and Prevention$121,902
K24 · FY2022 · AG · contact PI
Association of cumulative exposure to metformin and other T2D medications with cognitive impairment and AD/ADRD biomarkers$81,454
U19 · FY2022 · AG · contact PI
Metformin in Alzheimer's dementia Prevention (MAP)$9,597,463
R01 · FY2021 · AG · contact PI
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi Ethnic Study of Atherosclerosis (MESA) Multisite Studyof AD$3,899,242
R01 · FY2021 · AG
Diabetes and brain amyloid in middle aged Hispanics$3,234,050
R01 · FY2021 · AG · contact PI
Are there ethnic differences in brain amyloid and tau in the seventh decade of life?$1,420,510
R01 · FY2021 · AG · contact PI
Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)$1,041,032
R01 · FY2021 · AG
Testing Olfaction in Primary care to detect Alzheimer's disease and other Dementias (TOPAD)$750,182
R01 · FY2021 · AG · contact PI
Columbia Center for Interdisciplinary Research on Alzheimer's Disease Disparities (CIRAD)$683,873
P30 · FY2021 · AG
Research Education Core$265,447
P30 · FY2021 · AG · contact PI
Midcareer Award for Research in Dementia Risk Factors and Prevention$180,895
K24 · FY2021 · AG · contact PI
Pilot-Core$140,370
P30 · FY2021 · AG · contact PI
Metformin in Alzheimer's dementia Prevention (MAP)$5,980,939
R01 · FY2020 · AG · contact PI
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi Ethnic Study of Atherosclerosis (MESA) Multisite Studyof AD$3,609,964
R01 · FY2020 · AG
Metformin in Alzheimer's dementia Prevention (MAP)$3,234,307
R01 · FY2020 · AG · contact PI
Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)$2,659,030
R01 · FY2020 · AG
Testing Olfaction in Primary care to detect Alzheimer's disease and other Dementias (TOPAD)$875,377
R01 · FY2020 · AG · contact PI
Columbia Center for Interdisciplinary Research on Alzheimer's Disease Disparities (CIRAD)$690,010
P30 · FY2020 · AG
Measurement and estimation of lucidity prevalence in persons with dementia and neurological disorders$397,172
R21 · FY2020 · AG
Research Education Core$265,835
P30 · FY2020 · AG · contact PI
Midcareer Award for Research in Dementia Risk Factors and Prevention$180,895
K24 · FY2020 · AG · contact PI
Testing Olfaction in Primary care to detect Alzheimer's disease and other Dementias (TOPAD)$112,023
R01 · FY2020 · AG · contact PI
Metformin in Alzheimer's dementia Prevention (MAP)$81,057
R01 · FY2020 · AG · contact PI
Metformin in Alzheimer's dementia Prevention (MAP)$4,296,110
R01 · FY2019 · AG · contact PI
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi Ethnic Study of Atherosclerosis (MESA) Multisite Studyof AD$3,573,149
R01 · FY2019 · AG
Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)$2,011,249
R01 · FY2019 · AG
Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease$1,555,003
RF1 · FY2019 · AG · contact PI
Are there ethnic differences in brain amyloid and tau in the seventh decade of life?$1,471,549
R01 · FY2019 · AG · contact PI
Diabetes Status and Brain Amyloid in Middle Aged Hispanics$1,193,897
R01 · FY2019 · AG · contact PI
Auditory, olfactory, and motor correlates of in-vivo AD neuropathology and cognitive decline in late-middle age$821,822
R56 · FY2019 · AG · contact PI
Testing Olfaction in Primary care to detect Alzheimer's disease and other Dementias (TOPAD)$774,053
R01 · FY2019 · AG · contact PI
Columbia Center for Interdisciplinary Research on Alzheimer's Disease Disparities (CIRAD)$690,888
P30 · FY2019 · AG
Brain Insulin Resistance and Development of Alzheimers Disease$373,570
R01 · FY2019 · AG
Research Education Core$265,890
P30 · FY2019 · AG · contact PI
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi Ethnic Study of Atherosclerosis (MESA) Multisite Studyof AD$113,789
R01 · FY2019 · AG
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi Ethnic Study of Atherosclerosis (MESA) Multisite Studyof AD$3,663,134
R01 · FY2018 · AG
Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)$2,359,595
R01 · FY2018 · AG
Are there ethnic differences in brain amyloid and tau in the seventh decade of life?$1,497,958
R01 · FY2018 · AG · contact PI
Diabetes Status and Brain Amyloid in Middle Aged Hispanics$1,196,770
R01 · FY2018 · AG · contact PI
Testing Olfaction in Primary care to detect Alzheimer's disease and other Dementias (TOPAD)$785,438
R01 · FY2018 · AG · contact PI
Columbia Center for Interdisciplinary Research on Alzheimer's Disease Disparities (CIRAD)$706,388
P30 · FY2018 · AG
Research Education Core$207,199
P30 · FY2018 · AG · contact PI
Midcareer Award for Research in Dementia Risk Factors and Prevention$180,895
K24 · FY2018 · AG · contact PI
Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease$2,373,535
RF1 · FY2017 · AG · contact PI
Are there ethnic differences in brain amyloid and tau in the seventh decade of life?$1,537,002
R01 · FY2017 · AG · contact PI
Diabetes Status and Brain Amyloid in Middle Aged Hispanics$1,217,202
R01 · FY2017 · AG · contact PI
Testing Olfaction in Primary care to detect Alzheimer's disease and other Dementias (TOPAD)$811,920
R01 · FY2017 · AG · contact PI
New York City Hispanic Dementia Caregiver Research Program (NHiRP)$520,583
R01 · FY2017 · NR · contact PI
Midcareer Award for Research in Dementia Risk Factors and Prevention$180,895
K24 · FY2017 · AG · contact PI
Diabetes Status and Brain Amyloid in Middle Aged Hispanics$650,341
R01 · FY2016 · AG · contact PI
Diabetes Status and Brain Amyloid in Middle Aged Hispanics$614,394
R01 · FY2016 · AG · contact PI
New York City Hispanic Dementia Caregiver Research Program (NHiRP)$594,828
R01 · FY2016 · NR · contact PI
Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease$498,270
RF1 · FY2016 · AG · contact PI
Midcareer Award for Research in Dementia Risk Factors and Prevention$180,895
K24 · FY2016 · AG · contact PI
Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease$5,294,619
RF1 · FY2015 · AG · contact PI
Diabetes Status and Brain Amyloid in Middle Aged Hispanics$669,312
R01 · FY2015 · AG · contact PI
New York City Hispanic Dementia Caregiver Research Program (NHiRP)$529,336
R01 · FY2015 · NR · contact PI
New York City Hispanic Dementia Caregiver Research Program (NHiRP)$158,893
R01 · FY2015 · NR · contact PI
New York City Hispanic Dementia Caregiver Research Program (NHiRP)$66,582
R01 · FY2015 · NR · contact PI
New York City Hispanic Dementia Caregiver Research Program (NHiRP)$542,090
R01 · FY2014 · NR · contact PI
New York City Hispanic Dementia Caregiver Research Program (NHiRP)$533,205
R01 · FY2013 · NR · contact PI
COLUMBIA CENTER FOR HEALTH OF URBAN MINORITIES (CHUM)$1,640,631
P60 · FY2012 · MD · contact PI
COLUMBIA CENTER FOR HEALTH OF URBAN MINORITIES (CHUM)$277,603
P60 · FY2012 · MD · contact PI
COLUMBIA CENTER FOR HEALTH OF URBAN MINORITIES (CHUM)$1,216,868
P60 · FY2011 · MD · contact PI
Northern Manhattan Initiative for Minority Involvement in Clinical Trials$786,313
U24 · FY2011 · MD
Environmental health disparities research in NOCEMHD$572,320
P60 · FY2011 · MD · contact PI
COLUMBIA CENTER FOR HEALTH OF URBAN MINORITIES (CHUM)$200,000
P60 · FY2011 · MD · contact PI
COLUMBIA CENTER FOR HEALTH OF URBAN MINORITIES (CHUM)$1,646,812
P60 · FY2010 · MD · contact PI
Columbia Center for the Health of Urban Minorities - NOMA CERED$1,399,981
P60 · FY2010 · MD · contact PI
Pilot Trial of Metformin in Amnestic MCI$458,126
R01 · FY2010 · AG · contact PI
COLUMBIA CENTER FOR HEALTH OF URBAN MINORITIES (CHUM)$1,095,446
P60 · FY2009 · MD · contact PI
Pilot Trial of Metformin in Amnestic MCI$614,418
R01 · FY2009 · AG · contact PI
COLUMBIA CENTER FOR HEALTH OF URBAN MINORITIES (CHUM)$363,639
P60 · FY2009 · MD · contact PI
Cognition in the informatics for diabetes education and telemedicine$287,116
P60 · FY2009 · MD · contact PI
Pilot Trial of Metformin in Amnestic MCI$611,057
R01 · FY2008 · AG · contact PI
Cognition in the informatics for diabetes education and telemedicine$425,636
P60 · FY2008 · MD · contact PI
VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE$178,049
P01 · FY2008 · AG · contact PI
VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE$211,005
P01 · FY2007 · AG · contact PI
VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE$196,708
P01 · FY2006 · AG · contact PI
VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE$199,345
P01 · FY2005 · AG
Vascular factors, amyloid beta, and Alzheimer's disease$189,409
K08 · FY2004 · AG
VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE$155,181
P01 · FY2004 · AG
Vascular factors, amyloid beta, and Alzheimer's disease$189,804
K08 · FY2003 · AG
Vascular factors, amyloid beta, and Alzheimer's disease$184,342
K08 · FY2002 · AG